Furthermore, results from this mouse experiment suggest that individuals who take statins may be protected from AHR-mediated steatosis, but are at greater risk for TCDD-elicited liver injury and alterations in glycogen metabolism in a sex-specific manner. The gene discussed is AHR; the disease is steatosis.